Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPV-06 in Inflammatory Knee Osteoarthritis
NCT06605963Phase 2Not yet recruiting
- Sponsor
- Peptinov
- Start
- Apr 2027
- Primary completion
- Dec 2030
- Modality
- Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of PPV-06 in osteoarthritis (OA), sponsored by Peptinov. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
PPV-06
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06605963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605963.